Gastroesophageal Junction Carcinoma (GEJC)
specificA carcinoma that arises from the gastroesophageal junction. The vast majority of cases are adenocarcinomas. Rare cases are neuroendocrine carcinomas.
9
Centers
9
Active Trials
—
Cancer Funding
Top Centers for Gastroesophageal Junction Carcinoma (GEJC)(9)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 55.6 |
| 2 | UF Health Cancer InstituteGainesville, FL NCI Clinical Active Research Program | 55.6 |
| 3 | Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program | 55.6 |
| 4 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program | 55.6 |
| 5 | Stephenson Cancer CenterOklahoma City, OK NCI Clinical Active Research Program | 55.6 |
| 6 | Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive Active Research Program | 55.6 |
| 7 | Boston University Cancer CenterBoston, MA Active Research Program | 55.6 |
| 8 | Princess Margaret Cancer CentreToronto, ON Active Research Program | 55.6 |
| 9 | Louisiana Cancer Research CenterNew Orleans, LA Active Research Program | 55.6 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →